Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.28 | 1.93 |
NAV | ₹30.09 | ₹37.55 |
Fund Started | 20 Jun 2019 | 25 Jun 2018 |
Fund Size | ₹881.52 Cr | ₹5024.00 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Returns
1 Year | 37.47% | 50.65% |
3 Year | 16.66% | 22.29% |
5 Year | 24.05% | 30.36% |
Holding Analysis
Equity | 93.63% | 97.87% |
Cash | 6.37% | 2.13% |
Top Holdings
Top 10 Holdings |
|
|
Fund Manager
Name | Dhaval Joshi | Dharmesh Kakkad |
Start Date | 21 Nov 2022 | 23 Feb 2021 |
About Fund
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 20 Jun 2019 | 25 Jun 2018 |
